These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6396027)

  • 1. [Possibilities and limits of non-hormonal therapy of the menopausal syndrome].
    Piccione E; Sesti F; Manna C
    Clin Ter; 1984 Nov; 111(4):359-65. PubMed ID: 6396027
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
    De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new therapeutic approach to menopausal sudden flushes and psychofunctional disorders (author's transl)].
    Quereux C; Ezes H; Deltour G; Decaux J; Dorangeon P; Wahl P
    Sem Hop; 1980 Oct; 56(37-38):1453-9. PubMed ID: 6254160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New data on the physiology and treatment of vasomotor menopausal flushing].
    Buvat J; Buvat-Herbaut M
    LARC Med; 1983 Apr; 3(4):236, 241, 243-5. PubMed ID: 6137742
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of Agreal in the treatment of the menopause].
    Marais C
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):156-62. PubMed ID: 3992113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis and treatment of various forms of the climacteric syndrome].
    Smetnik VP; Balan VE; Butareva LB
    Akush Ginekol (Mosk); 1986 Jul; (7):34-7. PubMed ID: 2945458
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an antidopaminergic drug on LH, FSH and PRL levels in post-menopausal women.
    Venturini PL; Alibrandi MP; Costantini S; Grondona A; Morano S; Penna L; Valenzano M; Ragni N
    Acta Eur Fertil; 1981 Sep; 12(3):293-4. PubMed ID: 6803504
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
    Tortonese DJ
    Endocrinology; 1999 Feb; 140(2):750-7. PubMed ID: 9927302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intractable menopausal disorders cured by veralipride (author's transl)].
    Angeli S; Fougère P
    Sem Hop; 1982 Jan; 58(2):111-2. PubMed ID: 6276994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerance to veralipride administered for an extended time].
    Milliez J
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):27-8, 31. PubMed ID: 6531585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Veralipride and menopause].
    Laffargue F; Viala JL; Durand G
    Sem Hop; 1983 Sep; 59(29-30):2127-30. PubMed ID: 6312585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine-induced inhibition of plasma dopamine, noradrenaline and adrenaline responses to LH-RF.
    Van Loon GR
    Nature; 1978 Sep; 275(5678):331-2. PubMed ID: 357990
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in nalorphine-induced hyperprolactinaemia after bromocriptine or sulpiride administration.
    Barreca T; Magnani G; Sannia A; Rolandi E
    Eur J Clin Pharmacol; 1982; 22(4):375-6. PubMed ID: 7106173
    [No Abstract]   [Full Text] [Related]  

  • 18. [The modification of thyroid dysfunction by hormone substitution in the climacteric].
    Kurz H; Metka M; Enzelsberger H; Heytmanek G; Schurz B; Huber J; Spona J
    Gynakol Rundsch; 1989; 29(4):243-5. PubMed ID: 2560762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modifications of the incretory pituitary response of prolactin to sulpiride after treatment with bromocryptin].
    Gianrossi R; Gallamini A; Nizzo MC; Murialdo G; Peirano L
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1568-71. PubMed ID: 1037380
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].
    Renaud R; Macler J
    Sem Hop; 1981 Feb 18-25; 57(7-8):353-5. PubMed ID: 6261369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.